Nexalin Technology (NXLIW) Competitors $0.0093 -0.01 (-39.34%) Closing price 09/19/2025Extended Trading$0.01 0.00 (0.00%) As of 09/19/2025 06:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock NXLIW vs. AIMDW, BBLGW, DHAIW, COCHW, HSCSW, IINNW, PETVW, QSIAW, MDAIW, and TNONWShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include Ainos (AIMDW), Bone Biologics (BBLGW), DIH Holding US (DHAIW), Envoy Medical (COCHW), Heart Test Laboratories (HSCSW), Inspira Technologies Oxy B.H.N. (IINNW), PetVivo (PETVW), Quantum-Si (QSIAW), Spectral AI (MDAIW), and Tenon Medical (TNONW). These companies are all part of the "medical devices" industry. Nexalin Technology vs. Its Competitors Ainos Bone Biologics DIH Holding US Envoy Medical Heart Test Laboratories Inspira Technologies Oxy B.H.N. PetVivo Quantum-Si Spectral AI Tenon Medical Nexalin Technology (NASDAQ:NXLIW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends. Does the media refer more to NXLIW or AIMDW? In the previous week, Nexalin Technology had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for Nexalin Technology and 0 mentions for Ainos. Ainos' average media sentiment score of 1.91 beat Nexalin Technology's score of 1.45 indicating that Ainos is being referred to more favorably in the news media. Company Overall Sentiment Nexalin Technology Positive Ainos Very Positive Is NXLIW or AIMDW more profitable? Company Net Margins Return on Equity Return on Assets Nexalin TechnologyN/A N/A N/A Ainos N/A N/A N/A Which has better valuation and earnings, NXLIW or AIMDW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexalin Technology$174.81KN/AN/AN/AN/AAinos$110.87KN/AN/AN/AN/A SummaryNexalin Technology beats Ainos on 2 of the 3 factors compared between the two stocks. Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXLIW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXLIW vs. The Competition Export to ExcelMetricNexalin TechnologyMedical Devices IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.51B$6.03B$10.56BDividend YieldN/A2.44%5.92%4.70%P/E RatioN/A264.7876.4426.46Price / SalesN/A139.64582.24128.91Price / CashN/A15.9938.1961.33Price / BookN/A3.8212.516.45Net IncomeN/A$132.05M$3.30B$277.12M7 Day PerformanceN/A993,920.88%28,070.97%1.50%1 Month PerformanceN/A1,079,676.95%30,461.56%7.93%1 Year PerformanceN/A1,257,081.89%35,708.14%36.01% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLIWNexalin TechnologyN/A$0.01-39.3%N/A-91.0%$0.00$174.81K0.006Positive NewsShort Interest ↓Gap DownHigh Trading VolumeAIMDWAinosN/A$0.17+25.3%N/AN/A$0.00$110.87K0.0040Gap UpBBLGWBone BiologicsN/A$10.39-3.7%N/AN/A$0.00N/A0.002Positive NewsGap DownDHAIWDIH Holding USN/A$0.02+19.6%N/A-64.0%$0.00$64.47M0.00N/ANews CoveragePositive NewsShort Interest ↓Gap UpCOCHWEnvoy MedicalN/A$0.03+0.6%N/A-60.6%$0.00$222K0.0034Positive NewsShort Interest ↑Gap UpHSCSWHeart Test LaboratoriesN/A$0.15+0.1%N/A+216.6%$0.00$6.25K0.0010Positive NewsIINNWInspira Technologies Oxy B.H.N.N/A$0.33-7.1%N/A+24.5%$0.00N/A0.0020Positive NewsShort Interest ↑PETVWPetVivoN/A$0.06flatN/AN/A$0.00$1.05M0.0020QSIAWQuantum-SiN/A$0.29-9.4%N/A+211.8%$0.00$3.41M0.00150Positive NewsShort Interest ↓MDAIWSpectral AIN/A$0.70+1.6%N/A+628.3%$0.00$27.55M0.0083TNONWTenon MedicalN/A$0.02-16.8%N/A-46.0%$0.00$2.95M0.0022Positive NewsShort Interest ↑Gap Down Related Companies and Tools Related Companies AIMDW Competitors BBLGW Competitors DHAIW Competitors COCHW Competitors HSCSW Competitors IINNW Competitors PETVW Competitors QSIAW Competitors MDAIW Competitors TNONW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXLIW) was last updated on 10/2/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredThis Biotech has a clinical approach that intrigues investorsThis biotech is gearing up for Phase 2 trials with a strategy to unlock multiple approvals from one study. ...i2i Marketing Group, LLC | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.